Ken Fisher Denali Therapeutics Inc. Transaction History
Fisher Asset Management, LLC
- $227 Billion
- Q1 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 1,364,959 shares of DNLI stock, worth $18 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,364,959
Previous 792,499
72.23%
Holding current value
$18 Million
Previous $16.2 Million
14.93%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$174 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$160 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$156 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$151 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$89.4 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.77B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...